Lyell Immunopharma (LYEL) Gains from Sales and Divestitures (2020 - 2026)
Lyell Immunopharma (LYEL) recorded Gains from Sales and Divestitures of -$117,000 in Q2 2026, compared with -$2.47 million a year earlier.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Gains from Sales and Divestitures (2020 - 2026) Analysis & Trends
On a TTM basis, Lyell Immunopharma's Gains from Sales and Divestitures came in at $298,000 as of Jun 30, 2026; for FY2025, it was -$3.34 million.
- Across earlier years, Gains from Sales and Divestitures came in at -$1.34 million in FY2024, -$1.51 million in FY2023, -$103,000 in FY2022 and -$1.21 million in FY2021.
- Quarterly Gains from Sales and Divestitures has ranged from -$2.47 million in Q2 2025 to $249,000 in Q3 2025 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Lyell Immunopharma | 216.66 Mn | 216.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -117,000.00 |
| Dec 31, 2025 | 166,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Jun 30, 2025 | -2.47 Mn |
| Mar 31, 2025 | -1.29 Mn |
| Dec 31, 2024 | -924,000.00 |
| Sep 30, 2024 | -402,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Dec 31, 2023 | -437,000.00 |
| Sep 30, 2023 | -642,000.00 |
| Jun 30, 2023 | -430,000.00 |
| Dec 31, 2022 | -6,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Mar 31, 2022 | -84,000.00 |
| Dec 31, 2021 | -674,000.00 |
| Sep 30, 2021 | -212,000.00 |
| Jun 30, 2021 | -324,000.00 |
| Dec 31, 2020 | 4.88 Mn |
API Access
Lyell Immunopharma Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();